Cooper Companies Medical Device Company Intelligence Report

Date: July 22, 2011
Pages: 38
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C43E9986B7DEN
Leaflet:

Download PDF Leaflet

Cooper Companies Medical Device Company Intelligence Report
The Cooper Companies manufactures and markets speciality healthcare products through its CooperVision and CooperSurgical divisions.

CooperVision (CVI), headquartered in Pleasanton, California, US, manufactures and markets a broad range of contact lenses and, following its acquisition of Ocular Sciences in 2005, became one of the most successful players in this market. CVI’s primary offices are in the US and the UK and its manufacturing facilities are located in the US, the UK and Puerto Rico. Its principal markets are the US, Europe and the Asia-Pacific region.

CooperSurgical (CSI), based on Trumbull, Connecticut, US, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories for women’s healthcare, which are primarily used by gynaecologists and obstetricians. The company has mainly developed through small acquisitions, purchasing over 30 businesses over the last 20 years. The most recent acquisition was in April 2011, when CSI acquired Apple Medical, a developer of obstetric and gynaecology products. CSI’s primary objective is to service the obstetricians and gynaecologists in the US, since the company believes this is a more US-centric profession. However, the company does have a presence in Europe.

CVI’s three largest competitors are Johnson & Johnson’s Vistakon division, CIBA Vision (owned by Novartis) and Bausch & Lomb. Together with CVI, these companies represent almost 95% of the global soft contact lens market.

CSI competes primarily with smaller technology-driven companies that generally offer only one or two product lines. However, the company is now expanding into the significantly larger hospital and out-patient surgical procedure market, which is dominated by larger competitors such as Johnson & Johnson’s Ethicon Endo-Surgery and Ethicon Women’s Health and Urology companies, Boston Scientific, Gyrus ACMI (an Olympus company) and Covidien.

For the financial year ended 31st October 2010 (fiscal 2010), The Cooper Companies reported net income of US$112.8 million on net sales of US$1,158.5 million. This represented increases of 12% and 7%, respectively, when compared with fiscal 2009. CVI generated 84% of The Cooper Companies’ revenue, while CSI accounted for the remaining 16% of net sales.

As of June 2011, The Cooper Companies had a total of approximately 7,100 employees.

This company report provides

Overview

Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review

Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus

Investigates the company’s aims and its areas of focus

Products

Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution

Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements

With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information please click on the link to, Medical Device Companies Analysis.
OVERVIEW

FINANCIAL REVIEW

First Half Fiscal Year 2011 Financial Results
  CVI
  CSI
Fiscal Year 2010 Financial Results
  CVI
  CSI
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

PRODUCTS

CVI
CSI

RESEARCH AND DEVELOPMENT

MANUFACTURING AND DISTRIBUTION

Manufacturing
Distribution

AGREEMENTS

CIBA Vision
Gebauer Medizintechnik
Advanced Medical Optics
Rohto Pharmaceutical Company
Eyefinity
Welch Allyn

MERGERS AND ACQUISITIONS

Apple Medical
Asahikasei Aime Assets
American Medical Systems Assets
JLJ Medical Devices International
Intuitive Surgical's Uterine Positioning System
Wallach Surgical Devices
Lone Star Medical Products
NeoSurg Technologies/Inlet Medical
Ocular Sciences
Opti-Centre
Milex Products
Argus Biomedical’s AlphaCor and AlphaSphere Products
SURx’ Radiofrequency Bladder Neck Suspension Technology
Avalon Medical
Prism Enterprises
SAGE BioPharma
Ackrad Laboratories
Orthometrix/Norland Medical Systems’ Bone Densitometry Business
Biocompatibles Eye Care
Medscand Medical
CL-Tinters Oy
©Espicom B July 2011 usiness Intelligence v
Cooper Companies Table of Contents
MedAmicus’ LuMax Fiber Optic Cystometry System
MedaSonics
Leisegang Medical’s Women’s Healthcare Products
BEI Medical Systems’ Women’s Healthcare Products
Aspect Vision Care Ltd
Marlow Surgical Technologies
Unimar
RUMI Uterine Manipulator

MINORITY INVESTMENTS

Quidel

DIVESTITURES

CooperVision Surgical
Quidel
Hospital Group of America

LITIGATION

Rembrandt Vision Technologies
Internal Revenue Service
Securities Litigation

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
The Cooper Companies – First Half Fiscal 2011 Financial Results
The Cooper Companies – First Half Fiscal 2011 Net Sales by Geographic Region
CVI – Selected First Half Fiscal 2011 Financial Results
CVI – First Half Fiscal 2011 Revenues By Key Product
CVI – First Half Fiscal 2011 Sales by Geographic Area
CSI – Selected First Half Fiscal 2011 Financial Results
The Cooper Companies – Annual Financial Results, Fiscal Years 2006-2010
The Cooper Companies – Annual Net Sales by Geographic Region, Fiscal Years 2006-2010
CVI – Selected Annual Financial Results, Fiscal Years 2008-2010
CVI – Annual Revenues By Key Product, Fiscal Years 2008-2010
CVI – Annual Revenues by Geographic Region, Fiscal Years 2008-2010
CSI – Selected Annual Financial Results, Fiscal Years 2008-2010
The Cooper Companies – Five-Year Financial Summary, Fiscal Years 2006-2010
Soft Contact Lens Market by Region and by Competitor, Q1 2011
Global Soft Lens Market – Modality Breakdown by Region, Q1 2011
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Product, Calendar Year 2010-2015
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Region, Calendar Year 2010-2015
CVI – Key Contact Lens Brands, July 2011
CSI Market Shares, Fiscal Year 2009
CooperSurgical – Key Products, July 2011
Cooper Companies – Annual R&D Expenditure, Fiscal Years 2008-2010
Agreements Summary
Mergers and Acquisitions Summary

LIST OF CHARTS

The Cooper Companies - Annual Net Sales and Operating Income, Fiscal Years 2006-2010
The Cooper Companies - Annual Net Sales by Geographic Region, Fiscal Years 2006-2010
CVI - Annual Sales and Operating Income, Fiscal Years 2008-2010
CVI - Annual Net Sales by Geographic Area, Fiscal Years 2008-2010
CSI - Annual Net Sales and Operating Income, Fiscal Years 2008-2010
Global Soft Contact Lens Market by Competitor, Q1 2011
CSI – Office-based Sales by Product Type, Fiscal 2010
CSI – Hospital Sales by Medical Procedure/Segment, Fiscal 2010
CSI – Fertility Clinic Sales by Product Type, Fiscal 2010
Skip to top


Ask Your Question

Cooper Companies Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: